 |
|
|
| |
Effectiveness of 12 or 24 week LDV-SOF and 12 week LDV-SOF + RBV in Treatment-Experienced Patients with Cirrhotic, Genotype 1 Hepatitis C: Real-world Experience from the TRIO Network
|
| |
| |
Reported by Jules Levin
AASLD Nov 13-17 2015 San Francisco
Michael P. Curry1, Bruce Bacon2, Douglas Dieterich3, Steven L. Flamm4, Lauren Guest5, Kris V. Kowdley6, Yoori Lee5, NaokyTsai7, ZobairYounossi8
1Beth Israel Deaconess Medical Center, 2Saint Louis University School of Medicine,3Mount Sinai School of Medicine, 4Northwestern University Feinberg School of Medicine,5Trio Health Analytics, 6 Swedish Liver Center and Transplant Program,
Swedish Medical Center, 7Queens Medical Center, University of Hawaii, 8Center for Liver Diseases, Department of Medicine, InovaFairfax Hospital
|
| |
|
|
|
|
|
